Oncogenic viruses are responsible for approximately 20% of cancers globally, making their surveillance a critical public health challenge. Viruses such as human papillomavirus (HPV), hepatitis B and C viruses, and certain human polyomaviruses play central roles in initiating cancerous transformations in infected hosts. Unfortunately, because these viruses often lead to asymptomatic infections that may persist for years or even decades, their detection before malignancy arises remains difficult. Dr. Anthony Maresso, a molecular virologist at Baylor, highlights that traditional clinical approaches to identify such infections often lag behind, limiting early intervention strategies. Inspired by successes in viral wastewater analysis, his team explored whether similar surveillance could extend to monitoring oncogenic viruses community-wide.

Wastewater presents an untapped reservoir of viral genetic material shed by individuals through urine, feces, and skin cells that ultimately aggregate in sewage systems. By employing advanced genetic sequencing on these samples, scientists can attain a comprehensive snapshot of viral circulation without infringing on individual privacy or requiring invasive testing. Dr. Justin Clark, an assistant professor at Baylor, remarks that this environmental surveillance circumvents many barriers inherent to clinical diagnostics, yielding population-level insights capable of guiding public health policies more responsively.

The concept of monitoring viral pathogens via wastewater is not new, tracing its origins back over half a century when it was first utilized to detect poliovirus. More recently, during the COVID-19 pandemic, Baylor researchers were instrumental in pioneering wastewater surveillance to track SARS-CoV-2 variants and prevalence, providing invaluable data that anticipated outbreaks and guided healthcare resource allocation. Building on this expertise, the Texas Wastewater and Environmental Biomonitoring (TexWEB) initiative commenced viral genomic sequencing of wastewater from major Texan cities, sampling across a wide geographic and demographic spectrum since mid-2022.

This study employs a cutting-edge hybrid-capture genetic sequencing technique, capable of detecting over 3,000 distinct human viruses while simultaneously identifying novel viral mutations. The method enriches viral sequences from wastewater samples and subject them to high-throughput sequencing, generating granular data about virus presence, relative abundance, and evolutionary changes. Harihara Prakash, the study’s first author and bioinformatics analyst, emphasizes that this technology offers unparalleled resolution for viral surveillance within complex environmental samples.

Between May 2022 and May 2025, more than 40 wastewater collection points in 16 Texan cities were sampled, representing roughly 25% of the state’s population. The deep sequencing and computational analyses provide temporal dynamics of viral populations, enabling the team to discern both seasonal fluctuations and long-term trends in oncogenic virus prevalence. These data demonstrate not only viral presence but also shifts in viral dominance and diversity within communities.

All known oncogenic viruses were detected in the analyzed wastewater samples. Among the predominant viruses found were HPV, hepatitis B and C viruses, and human polyomaviruses associated with various cancers. The study further identified Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus, both implicated in lymphomas and rare blood cancers. This comprehensive detection attests to the robustness of wastewater metagenomics in capturing viral diversity relevant to cancer etiology.

Intriguingly, the data reveal an upward trajectory in the abundance of multiple oncogenic viruses over the three-year study period. Significant surges following 2024 were noted in HPV, EBV, and certain polyomaviruses. The researchers hypothesize that these spikes may correlate with increased social interactions, including seasonal travel and heightened interpersonal contact during academic sessions, coinciding with the relaxation of COVID-19 social distancing mandates. Such epidemiological insights underscore the influence of behavioral and policy changes on viral transmission dynamics.

The team delved deeper into HPV subtype distributions due to its prominent role in cervical and oropharyngeal cancers. Despite the high-risk types being generally less prevalent than low-risk ones, the high-risk strains, particularly HPV-16 and HPV-18, exhibited distinct increasing trends late in the surveillance window. Notably, HPV-16 consistently outnumbered HPV-18 across samples, aligning with global clinical observations about their relative oncogenic burden. These findings underscore the method’s precision in parsing subtype-specific epidemiology from environmental samples.

Critical to public health implementation, the researchers detected all nine HPV genotypes targeted by the Gardasil 9 vaccine, validating wastewater surveillance as a tool to monitor vaccine-preventable oncogenic viruses. This capability holds promise for evaluating vaccine coverage effectiveness and identifying regions where immunization uptake may be insufficient, providing actionable data to optimize vaccination strategies and ultimately reduce virus-induced cancer incidence.

This pioneering research firmly establishes that oncogenic viruses can be tracked non-invasively via wastewater, broadening our capacity to surveil viral cancer risks within populations. By elucidating viral prevalence patterns and their temporal evolution, this approach opens new avenues to design timely and targeted public health interventions. Dr. Maresso stresses the prospective translation of these insights into tangible cancer prevention measures, harnessing environmental virology as an adjunct to traditional clinical epidemiology.

The study’s interdisciplinary team from Baylor College of Medicine and the University of Texas Health Science Center at Houston collectively contributed to this comprehensive effort. With generous funding from multiple state and federal sources, including the Texas Legislature and NIH, the research exemplifies the synergy of innovative technology, bioinformatics, and public health priorities converging to combat virus-associated cancers.

As wastewater metagenomics continues to evolve, its integration with epidemiological modeling and clinical surveillance promises an unprecedented vantage point on community health. This initiative exemplifies how environmental data streams can supplement conventional health monitoring to anticipate viral threats before they culminate in disease, fostering a paradigm shift in preventative oncology and viral epidemiology. The success of this approach embodies a beacon for future efforts, illuminating the potential of wastewater not just as waste but as a rich, real-time source of viral intelligence.

Subject of Research: Human tissue samples

Article Title: Detection, persistence, and rising prevalence of oncogenic viruses revealed by wastewater metagenomics

News Publication Date: 13-May-2026

Web References:

• https://journals.asm.org/eprint/NAW85DPAZMGV9SR2YDHQ/full
• https://tephi.texas.gov/early-detection
• http://dx.doi.org/10.1128/aem.00547-26

References:
Perez RK, Ross M, Tisza M, Javornik Cregeen SJ, Petrosino JF, Deegan J, Boerwinkle E, Maresso AN, Clark J, Prakash H. Detection, persistence, and rising prevalence of oncogenic viruses revealed by wastewater metagenomics. Applied and Environmental Microbiology. 2026; DOI: 10.1128/aem.00547-26.

Keywords: Wastewater surveillance; Oncogenic viruses; Human papillomavirus; Epstein-Barr virus; Polyomaviruses; Viral metagenomics; Public health; Viral epidemiology; Cancer prevention; Hybrid-capture sequencing

The rise of synthetic cannabinoids in recent years has sparked significant concern among public health officials. These substances, often marketed as “legal highs” or “herbal incense,” can be far more potent and unpredictable than their natural counterparts. The challenges posed by their chemical diversity make it essential for researchers to identify specific drug targets for monitoring purposes. In this study, the authors outline a systematic approach to selecting target residues of synthetic cannabinoids, which can then be traced in wastewater samples. This novel technique holds the potential for timely public health assessments and interventions, especially during drug outbreaks.

Understanding the chemical composition of synthetic cannabinoids such as AKB-48F is crucial for researchers and policymakers alike. 4F-ABINACA, one of the primary substances studied, is designed to bind to the same cannabinoid receptors in the brain as THC, the active compound in marijuana. However, the similarity in receptor binding does not translate to comparable safety profiles. Many synthetic cannabinoids have been linked to severe health complications, including seizures, agitation, and even death. By monitoring the trace residues of these substances in wastewater, researchers can gauge usage levels and identify patterns that could inform public health responses.

One of the key findings of the study is the importance of selecting the right drug target residues. The researchers emphasized that not all compounds are equally detectable in wastewater, and some may degrade or transform during the wastewater treatment process. To be effective in monitoring, the selected residues must remain stable and detectable in the waste matrix. The study provides a detailed breakdown of various synthetic cannabinoid metabolites and their persistence in wastewater systems, which could significantly influence future monitoring strategies.

Moreover, the researchers highlighted the role of advanced analytical techniques, such as high-resolution mass spectrometry, in identifying synthetic cannabinoids within complex wastewater matrices. With these sophisticated methods, scientists can accurately pinpoint the presence of specific compounds even in low concentrations, contributing to a more comprehensive understanding of drug use in the environment. Not only does this enhance the reliability of the data collected, but it also opens doors for longitudinal studies that track the evolution of synthetic cannabinoid use over time.

There exists a growing body of literature on the implications of wastewater analysis for public health. The current research adds to this narrative by providing specific, actionable data on synthetic cannabinoids. By linking the occurrence of these substances in wastewater with public health outcomes, such as emergency medical calls related to drug use, researchers can create a clearer picture of the societal impacts of synthetic cannabinoids. This critical connection between environmental monitoring and health can contribute to reducing the harm associated with these drugs.

In addition, the global nature of synthetic cannabinoid production poses unique challenges for regulatory bodies. As chemists continue to create new analogs and modifications, ensuring that legislation keeps pace becomes increasingly difficult. Wastewater-based epidemiology serves as a real-time snapshot of drug trends, allowing health authorities to adapt their strategies in response to emerging threats. By identifying spikes in usage or the introduction of new compounds, public health responses can be tailored to address the specific needs of a community.

The study also discusses the ethical considerations surrounding wastewater monitoring. While the benefits of tracking drug use through this method are apparent, researchers must also navigate the fine line between public health surveillance and personal privacy. In analyzing wastewater, individuals are not identified; yet, the aggregate data can reveal substantial insights into societal behaviors. Balancing these interests remains a vital part of the ongoing discourse among scientists, ethicists, and policymakers.

In essence, Gish and colleagues provide a powerful framework for synthetic cannabinoid monitoring. A significant takeaway is the necessity for collaboration among different disciplines, including toxicology, environmental science, public health, and law enforcement. The interdisciplinary nature of this research is what allows for effective action against the rising tide of synthetic drug use. With stakeholders from various fields working together, the potential to create more effective public health policies increases.

Furthermore, the findings underscore the dynamic nature of drug monitoring as technology evolves. Advances in data collection methods and analytical techniques have the potential to revolutionize how researchers view hydrochemical data, leading to better predictive models for understanding drug trends. This will not only improve the quality of public health information but also enhance the speed and efficacy of intervention strategies.

As we look toward the future, the implications of this research hold much promise. Updated screening methods will continue to strengthen the ability of public health officials to respond promptly to the emergence of synthetic cannabinoids in communities. The challenge posed by these substances is complex and multifaceted, but the proactive measures outlined in this study provide a glimmer of hope. Continuous refinement and expansion of wastewater monitoring protocols could create a robust safety net for public health, ultimately minimizing the harm caused by these dangerous drugs.

In conclusion, as synthetic cannabinoids become an increasingly prominent issue worldwide, the methodology provided in this study is essential for informed public health responses. By focusing on drug target residues through wastewater-based epidemiology, the research paves the way for future studies that can affect real change in communities wrestling with drug-related challenges. As this field continues to grow, it is crucial that scientists and policymakers work in concert to ensure the safety and well-being of populations faced with the complexities of synthetic drug use.

The implications of Gish and colleagues’ work extend beyond mere monitoring, touching on broader themes of community accountability, health equity, and environmental safety. Understanding and addressing the risks associated with synthetic cannabinoids will require nuanced approaches that integrate scientific discovery with social awareness. This research not only provides technical insights but also serves as a call to action for enhanced interdisciplinary cooperation aimed at fostering healthier communities.

Subject of Research: Synthetic cannabinoids monitoring through wastewater-based epidemiology.

Article Title: Drug target residue selection for synthetic cannabinoids monitoring by wastewater-based epidemiology: case study of the AKB-48F (4F-ABINACA or 4F-ABUTINACA).

Article References:

Gish, A., Richeval, C., Gaulier, JM. et al. Drug target residue selection for synthetic cannabinoids monitoring by wastewater-based epidemiology: case study of the AKB-48F (4F-ABINACA or 4F-ABUTINACA).
Environ Sci Pollut Res (2025). https://doi.org/10.1007/s11356-025-37084-x

Image Credits: AI Generated

DOI: 10.1007/s11356-025-37084-x

Keywords: wastewater-based epidemiology, synthetic cannabinoids, 4F-ABINACA, public health, drug monitoring, environmental safety

Despite these breakthroughs, the application of WBE on a global scale presents considerable technical challenges that require sophisticated data integration and analysis pipelines. The emergence of machine learning as a complementary discipline promises to revolutionize the way scientists interpret wastewater data, enabling more accurate detection, quantification, and prediction of pathogens within heterogeneous and noisy datasets. Machine learning algorithms excel in recognizing intricate patterns and disentangling signal from background noise, which is essential when dealing with the inherent variability of wastewater samples influenced by factors such as population size, sewer network configurations, and environmental conditions.

The COVID-19 pandemic catalyzed the rapid deployment and refinement of numerous wastewater surveillance programs worldwide. These initiatives generated vast quantities of genomic and chemical data derived from sequencing technologies. Integrating these datasets with demographic, epidemiological, and environmental context has become imperative to translate raw measurements into actionable knowledge. For instance, correlating viral RNA concentrations in wastewater with reported case counts allows for calibration of model outputs and enhances the predictive power of outbreak forecasting algorithms. However, this integration demands rigorous normalization methods to adjust for sampling inconsistencies, variable viral shedding rates, and dilution factors.

Normalization remains one of the primary technical obstacles in leveraging WBE data. Without accounting for fluctuations in wastewater flow rates, chemical degradation, and temporal sampling biases, raw pathogen concentrations can be misleading. Machine learning approaches—ranging from regression models to deep neural networks—are increasingly employed to address these challenges by learning complex normalization functions directly from the data. By incorporating auxiliary streams such as water quality parameters, flow metrics, and population mobility data, these models can dynamically correct for confounders, improving robustness and reliability.

Moreover, the heterogeneity of WBE data sources across different regions complicates the standardization and harmonization of surveillance efforts. Variability in sample collection methodologies, sequencing platforms, and target biomarkers limits comparability and pooled analyses at regional or global scales. Developing universally accepted protocols and metadata standards is therefore essential. Machine learning frameworks can facilitate this harmonization by enabling cross-study transfer learning, where models trained in one context adapt to novel sampling conditions, thereby amplifying their utility beyond localized implementations.

The potential of machine learning extends beyond data normalization. It can power early warning systems by identifying subtle shifts in pathogen signatures that may precede clinical case upticks. Unsupervised learning algorithms can detect emergent variants or antimicrobial resistance elements by clustering anomalous genomic features. Predictive modeling, augmented by contextual data such as vaccination rates or mobility patterns, can forecast disease trajectories and guide resource allocation. These capabilities position machine learning-augmented WBE as a cornerstone of future integrated health surveillance infrastructures.

Integrating WBE into broader health monitoring systems remains a subject of active research and development. Existing clinical surveillance often suffers from reporting lags, undersampling, and socioeconomic biases that hinder comprehensive population coverage. Wastewater analysis bypasses individual testing requirements and reflects the collective health of entire communities, including asymptomatic carriers. Machine learning facilitates the fusion of these complementary data streams, producing holistic public health dashboards that empower decision-makers with multi-faceted insights in real time.

However, realizing this vision requires addressing data privacy, ethical, and infrastructural hurdles. While wastewater data is aggregated and anonymized, linking surveillance results to specific locales or populations raises concerns about stigmatization and informed consent. Transparent governance frameworks must ensure equitable use of WBE data. Additionally, scaling surveillance networks demands sustained investment in laboratory capabilities, computational resources, and workforce training, alongside strategies for inclusive data sharing and collaboration across geopolitical boundaries.

Current advancements in sequencing technologies contribute to the evolving capabilities of WBE. High-throughput, next-generation sequencing allows for comprehensive profiling of microbial communities and pathogen variants within sewage samples. Machine learning models trained on these complex datasets have demonstrated efficacy in pinpointing variant-specific mutations, tracking evolutionary dynamics, and distinguishing co-circulating lineages. This granularity enables nuanced epidemiological interpretations previously unattainable via traditional diagnostic assays, offering a powerful complement to clinical genomic surveillance.

Moreover, machine learning aids in quantifying antimicrobial resistance (AMR) genes within wastewater, an increasingly critical public health concern. By integrating genomic data with environmental and usage parameters, predictive models can identify hotspots of resistance emergence, inform stewardship programs, and anticipate the impact of interventions. This multi-dimensional approach transcends conventional monitoring efforts, illuminating the interconnectedness of human health, microbial ecology, and environmental factors.

To fully harness these technological synergies, international collaboration and capacity building are indispensable. Developing interoperable data platforms and implementing shared analytical frameworks will accelerate method development and facilitate rapid responses to emerging threats. Initiatives fostering open data exchange and reproducible machine learning workflows stand to democratize access and expertise, enabling underserved regions to benefit from global surveillance advances without disproportionate resource burdens.

Looking forward, research efforts must prioritize the interpretability and transparency of machine learning models applied to WBE. While complex algorithms yield powerful predictions, their black-box nature poses challenges for regulatory acceptance and public trust. Emphasizing explainable AI techniques will foster confidence among stakeholders by providing mechanistic insights and quantifiable uncertainties associated with model outputs. This is crucial for embedding WBE-driven intelligence into routine public health practice and policy.

In conclusion, the fusion of wastewater-based epidemiology with cutting-edge machine learning methodologies marks a transformative juncture in global health surveillance. By navigating the technical complexities inherent in sampling, sequencing, and data integration, this interdisciplinary approach promises timely, cost-effective, and inclusive monitoring of infectious diseases and resistance threats. The continued evolution of frameworks that bridge WBE with clinical and environmental data pipelines will enhance the resilience of health systems worldwide, empowering proactive responses in an increasingly interconnected and vulnerable world. The challenges ahead are substantial, but the convergence of computational prowess and epidemiological insight heralds a new era in population health intelligence.

Subject of Research: The integration of wastewater-based epidemiology with machine learning for enhanced global health surveillance.

Article Title: Augmentation of wastewater-based epidemiology with machine learning to support global health surveillance.

Article References:
Aßmann, E., Greiner, T., Richard, H. et al. Augmentation of wastewater-based epidemiology with machine learning to support global health surveillance. Nat Water (2025). https://doi.org/10.1038/s44221-025-00444-5

Image Credits: AI Generated

Vaccination remains one of the most impactful medical interventions in history, yet its acceptance has faced growing challenges. Despite overwhelming scientific consensus on the benefits of vaccines, certain populations remain hesitant or opposed due to misinformation, conspiracy theories, or mistrust. The COVID-19 pandemic, while underscoring vaccination’s life-saving potential, also amplified an unprecedented wave of vaccine hesitancy fueled by social media misinformation. This paradoxical situation has driven researchers to seek more interactive and scalable ways to reach the public.

Central to the SWPS University project is the development of FLORA, a virtual nurse designed to simulate empathetic, engaging conversations about flu vaccination. Unlike static informational leaflets or impersonal questionnaires, FLORA employs a dynamic dialogue framework whereby users actively participate in a tailored discussion. The platform’s avatar exhibits human-like expressions and verbal cues that help replicate elements of real social interaction, enhancing the user’s sense of connection and trust. This approach leverages principles of social influence theory, which emphasizes the power of dialogue and relationship-building in changing attitudes and behaviors.

The research involved two large randomized controlled clinical trials comprising nearly 1,800 participants. Subjects were randomly assigned to one of three groups: one engaged in a virtual conversation with FLORA, the second completed a risk-assessment questionnaire regarding influenza complications, and the third read a conventional informational leaflet. The FLORA sessions incorporated personalized health assessments and risk discussions specifically designed to motivate vaccination, with some participants receiving an explicit prompt to get vaccinated.

Notably, the interactive dialogue elicited a significant decrease in perceived personal risk for post-influenza complications, particularly among individuals initially categorized as low-risk. This reduction in perceived vulnerability paradoxically corresponded with a heightened willingness to vaccinate within this group—a nuanced finding that underscores the complexity of risk perception in health decision-making. It suggests that engaging conversational contexts may recalibrate how individuals interpret health risks and benefits beyond simple informational delivery.

Perhaps more striking was the discovery that supplementing the dialogue with a direct, clear vaccination request amplified participants’ readiness to vaccinate by a factor of thirty-three compared to other groups. This result signals that while conversational engagement forms a critical foundation, integrating explicit behavioral calls-to-action can generate disproportionately larger effects. Such insights provide valuable guidance for designing future digital health interventions by combining empathetic dialogue with straightforward behavioral nudges.

The FLORA avatar’s design reflects a sophisticated understanding of communication science and human-computer interaction. By incorporating facial expressions, simulated emotions, and elements of humor, the virtual nurse bridges the empathetic gap that often poses a limitation in digital health tools. The research team emphasizes that demonstrating empathy—and not merely conveying information—is a crucial determinant of trust and persuasion in healthcare communication. These qualities confront the pervasive problem of “digital coldness” that can alienate users from technology-mediated health advice.

This research also aligns with broader shifts in healthcare that seek to alleviate the increasingly burdensome demands placed on clinicians. Medical professionals face mounting workloads that constrain their ability to engage patients extensively in vaccine-related dialogues. FLORA’s virtual assistant model offers a scalable solution that can complement healthcare delivery, potentially enriching patients’ understanding and positively influencing their vaccination decisions without additional strain on healthcare resources.

The SWPS University study contributes to the growing literature on computational social science by demonstrating how digital avatars can embody communication strategies traditionally reserved for human providers. This blend of technology and psychology exemplifies interdisciplinary innovation, harnessing artificial intelligence, behavioral science, and health communication to tackle pressing public health challenges.

Moving forward, researchers acknowledge that individual user differences, such as pre-existing attitudes towards vaccines and the perceived credibility of the virtual assistant, likely modulate the intervention’s impact. Future investigations will focus on optimizing avatar characteristics and dialogue structures to maximize effectiveness across diverse populations. Additionally, integrating such virtual dialogues into public health campaigns could create new avenues for combating vaccine misinformation on scalable platforms.

By offering a compelling example of how virtual agents can support health promotion efforts, FLORA embodies a promising frontier in digital public health. This research not only advances our understanding of social influence mechanisms in virtual environments but also opens pathways toward more accessible, interactive, and empathetic healthcare experiences in the 21st century.

Subject of Research: People

Article Title: A virtual assistant can persuade you to get vaccinated against the flu. Online dialogue as a tool of social influence in promoting vaccinations

News Publication Date: 10-Feb-2025

Web References:
https://www.sciencedirect.com/science/article/pii/S0277953625001546?via%3Dihub
http://dx.doi.org/10.1016/j.socscimed.2025.117825

References:

1. Hussain, A., Ali, S., Ahmed, M., & Hussain, S. (2018). The Anti-vaccination Movement: A Regression in Modern Medicine. Cureus.
2. Loomba, S., de Figueiredo, A., Piatek, S. J., de Graaf, K., & Larson, H. J. (2021). Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nature Human Behaviour, 5(3), Article 3. 01056-1.
3. Kim, S. S., Kaplowitz, S., & Johnston, M. (2004). The Effects of Physician Empathy on Patient Satisfaction and Compliance. Evaluation & the Health Professions, 27, 237–251.
4. Stewart, M. A. (1995). Effective physician-patient communication and health outcomes: A review. CMAJ: Canadian Medical Association Journal, 152(9), 1423–1433.
5. Thom, D. H., Hall, M. A., & Pawlson, L. G. (2004). Measuring patients’ trust in physicians when assessing quality of care. Health Affairs, 23(4), 124–132.

Image Credits: SWPS University

Keywords: Psychological science, Health care, Information technology, Computational social science